XWELL Inc (XWEL)
1.80
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.80
0.00 (0.00%)
Pre-Market: 20:00
XWELL Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.15M |
| June 30, 2023 | -0.12M |
| March 31, 2023 | -0.022M |
| December 31, 2022 | 0.279M |
| September 30, 2022 | -11.13M |
| June 30, 2022 | -2.586M |
| March 31, 2022 | -13.94M |
| December 31, 2021 | -9.429M |
| September 30, 2021 | -1.428M |
| June 30, 2021 | -0.133M |
| March 31, 2021 | 17.34M |
| December 31, 2020 | 36.86M |
| September 30, 2020 | 31.47M |
| June 30, 2020 | 43.11M |
| March 31, 2020 | 5.785M |
| December 31, 2019 | -0.36M |
| September 30, 2019 | 1.978M |
| June 30, 2019 | -0.287M |
| March 31, 2019 | -0.166M |
| December 31, 2018 | 2.879M |
| September 30, 2018 | -0.212M |
| June 30, 2018 | 3.197M |
| March 31, 2018 | -0.22M |
| December 31, 2017 | -0.043M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.391M |
| June 30, 2017 | 0.10M |
| March 31, 2017 | -0.361M |
| December 31, 2016 | -1.734M |
| September 30, 2016 | -0.277M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.05M |
| December 31, 2015 | -0.61M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 12.21M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 10.66M |
| March 31, 2014 | 2.796M |
| December 31, 2013 | 0.025M |
| September 30, 2013 | 1.212M |
| June 30, 2013 | 0.153M |
| March 31, 2013 | 0.174M |
| December 31, 2012 | 55.98M |
| September 30, 2012 | 29.72M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.778M |
| September 30, 2011 | 1.451M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-13.94M
Minimum
Mar 2022
43.11M
Maximum
Jun 2020
5.134M
Average
-0.022M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| Fonar Corp | -1.761M |
| ProPhase Labs Inc | 2.271M |
| Applied DNA Sciences Inc | 3.015M |
| Veracyte Inc | -0.864M |
| OncoCyte Corp | -0.03M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.201M |
| Cash from Investing (Quarterly) | 6.822M |
| Free Cash Flow | -18.45M |
| Free Cash Flow Per Share (Quarterly) | -0.8276 |
| Free Cash Flow to Equity (Quarterly) | -3.467M |
| Free Cash Flow to Firm (Quarterly) | -3.467M |
| Free Cash Flow Yield | -253.9% |